Literature DB >> 8494550

Inhibition of phosphatidylcholine secretion by stilbene disulfonates in alveolar type II cells.

A Chander1, N Sen.   

Abstract

Various agents stimulate the secretion of lung surfactant from alveolar type II cells by increasing intracellular Ca2+, cyclic adenosine-3':5'-monophosphate (cAMP), or diacylglycerol. A few agents, including the purified surfactant protein A, are known to inhibit the secretion by an unknown mechanism. In the present study, we demonstrated that stilbene disulfonic acids, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) and 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS), are potent but reversible inhibitors of lung surfactant secretion. The inhibition was concentration dependent, and the EC50 was 5 microM for DIDS and 50 microM for SITS. The inhibition was not specific to agonists for any one type of receptor, and was also observed for secretion stimulated by 8-bromo-cAMP, or tetradecanoyl phorbol acetate, suggesting that the site of inhibition was distal to the generation of intracellular second messengers. This was also supported by the failure of DIDS to block the stimulus-mediated increase in diacylglycerol content of type II cells. Further, DIDS and SITS were also inhibitory for basal secretion. Based on the reversibility of inhibition and the fact that inhibition was observed with both basal and stimulated secretion, we suggest that stilbene disulfonic acids affect a component of the exocytosis process that occurs at or near the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494550     DOI: 10.1016/0006-2952(93)90450-b

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Annexin A7 trafficking to alveolar type II cell surface: possible roles for protein insertion into membranes and lamellar body secretion.

Authors:  Avinash Chander; Tudevdagva Gerelsaikhan; Pavan K Vasa; Kelly Holbrook
Journal:  Biochim Biophys Acta       Date:  2013-02-19

2.  Secretagogues of lung surfactant increase annexin A7 localization with ABCA3 in alveolar type II cells.

Authors:  Tudevdagva Gerelsaikhan; Xiao-Liang Chen; Avinash Chander
Journal:  Biochim Biophys Acta       Date:  2011-09-02

3.  Methylamine decreases trafficking and packaging of newly synthesized phosphatidylcholine in lamellar bodies in alveolar type II cells.

Authors:  A Chander; N Sen; A M Wu; S Higgins; S Wadsworth; A R Spitzer
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  Annexin A7 and SNAP23 interactions in alveolar type II cells and in vitro: a role for Ca(2+) and PKC.

Authors:  Tudevdagva Gerelsaikhan; Pavan Kumar Vasa; Avinash Chander
Journal:  Biochim Biophys Acta       Date:  2012-06-16

5.  Coordinate packaging of newly synthesized phosphatidylcholine and phosphatidylglycerol in lamellar bodies in alveolar type II cells.

Authors:  A Chander; N Sen; S Wadsworth; A R Spitzer
Journal:  Lipids       Date:  2000-01       Impact factor: 1.880

6.  Calcium-dependence of synexin binding may determine aggregation and fusion of lamellar bodies.

Authors:  N Sen; A R Spitzer; A Chander
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

7.  Transient in utero disruption of cystic fibrosis transmembrane conductance regulator causes phenotypic changes in alveolar type II cells in adult rats.

Authors:  Ashraf Gad; Delon L Callender; Erin Killeen; Joseph Hudak; Malgosia A Dlugosz; Janet E Larson; J Craig Cohen; Avinash Chander
Journal:  BMC Cell Biol       Date:  2009-03-31       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.